Medical Devices & Equipment Company

TriAgenics

61%

Funding Goal $4,000,000
Funding Raised So Far $2,300,000
Funding Commitments $125,000
Funding Remaining $1,575,000
Funding Type Preferred Equity
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Company Overview

TriAgenics is an oral health company that has developed a treatment designed to prevent wisdom teeth from ever forming.

TriAgenics’ revolutionary Zero3™ TBA (3rd molar tooth bud ablation) is a one-minute, preventive-care treatment for children ages 6-12. Zero3 treatment is expected to eliminate ALL painful complications normally associated with having wisdom teeth surgically removed.

TriAgenics’ Zero3 technology is designed to gently warm the center of the patients’ developing wisdom tooth buds. This high-precision, minimally invasive treatment prevents tooth buds from ever developing into wisdom teeth. It is expected that there will be no recovery period following treatment, with no risk of dry socket and minimal risk of post-op infections. In sharp contrast, it takes an average of 3 days to recover from having wisdom teeth surgically removed.

In multiple live animal trials to date, the Zero3 TBA procedure has been 100% effective in preventing teeth from ever forming with no recovery problems. This patented treatment and technology offers parents and dental professionals a safe, effective and simple way to prevent the broad array of diseases, extensive damage and lifelong hazards caused by wisdom teeth.

lock icon

Invest in Company

Sign up or log in now to unlock profile details and access financials, company documents, and invest in companies.

Investor Sign Up
Investor Log In

Business Summary

Company Age
Employees
Sub-Industry
Prior Year Revenue
Current Year Revenue
Next Year Revenue

Products/Services

Zero3 TBA System

TriAgenics’ business model is similar to Align Technology’s Invisalign clear braces marketing strategy. Dentists will pay TriAgenics $350 per tooth bud for patient-specific Zero3 TBA treatment kits.

Treatment takes just seconds. TriAgenics’ custom 3TBA guide snaps onto patients’ teeth (like a mouthguard) to position the 3TBA handpiece tip quickly and accurately for precise treatment. Using less than 5 watts, the handpiece delivers a small thermal dose that gently warms each wisdom tooth bud from its center outwards. This low-energy treatment irreversibly blocks wisdom teeth from forming without causing damage outside the prescribed 4-8 mm treatment zone. The small puncture made by the handpiece requires no recovery time following treatment and eliminates all complications normally associated with wisdom tooth extraction.

Product development is complete. Zero3 TBA is protected by 24 U.S. and international patents. TriAgenics expects to obtain FDA approval in 2024.

Management

Leigh Colby
President Executive Officer
Leigh C......

Leigh C......, DDS, MBA, founded TriAgenics in 2016, where he serves as President & CEO. TriAgenics is dedicated to delivering the safest and simplest means of managing third molars. Leigh developed the core technology used in TriAgenics’ Zero3 TBA fully guided third molar tooth bud ablation system and conducted ground-breaking animal research that demonstrated the safety and efficacy of TriAgenics’ Zero3 TBA procedure. From 1995 to 2015, Leigh owned and operated Oregon Dental Care, a large single-site group practice with over 10,000 active patients. From 1986 to 1995, Leigh was the Vice President of Business Development at Surmodics (formerly BSI) where he worked with global medical device medical device companies to solve biocompatibility problems. In 1980 Leigh was the principal founder of Laserdyne Corporation, which continues to lead the industry in high-precision industrial laser machining solutions. In 1979 Leigh graduated from the University of Minnesota School of Dentistry.

Dave Watson
Director Operations
Dave W......

Dave W...... brings 25 years of leadership experience to the management team at TriAgenics, Inc. Mr. W...... worked for 15 years with IBM in Engineering, Manufacturing, and Product Development where he held key technical and senior management positions, including critical strategist at IBM Technology Products Division headquarters. He filled the positions of Director of Technology at Planar Systems, Inc., Director of Engineering at Fujitsu Ltd., Director of Manufacturing at Biotronik, Inc and VP of Engineering at Unilife Medical Solutions, Inc. Mr. W...... has patents in the fields of automated equipment and technology products. Mr. W...... is the Chief of Operations at TriAgenics, Inc. and is responsible for quality assurance, regulatory affairs, product development and manufacturing. He holds an MSME from the University of Texas and a BSME from California Polytechnic State University in California.

61%

Funding Goal $4,000,000
Funding Raised So Far $2,300,000
Funding Commitments $125,000
Funding Remaining $1,575,000
Funding Type Preferred Equity
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Documents

Contact

TriAgenics

Redmond, OR 97756, US

Top 10 Tips for Entrepreneurs Seeking Funding

Users who follow these tips increase their fundraising odds substantially.

  • Complete Your Funding Profile
    • Complete your funding profile with all sections filled, including your products and services, a complete management team with headshots, and slideshow with product images.
  • Complete a Business Plan (Optional)
    • Complete a Business Plan in EquityNet and refine your financial projections using the benchmarking alerts in the Business Plan Analysis report.
  • Upload Important Investment Documents
    • Upload and present any other important investment documents such as pitch decks, financial statements, and offering materials.
  • Use EquityNet Crowdcast
    • Use the EquityNet Crowdcast system to automatically email invitations to your contacts in order to build additional exposure for your company.
  • Construct Concise Introductory Messages
    • Construct and send a concise introductory message to investors, including primary reasons why they should want to invest such as KPIs, expected returns, and forecasted revenue.
  • Be Proactive in Messaging Investors
    • Be proactive in messaging many investors and include a simple way for them to connect with you for a web meeting or call, such as a Calendly link.
  • Use the Activity System
    • Use the Activity system to track interested investors, and send prompt follow-up messages to investors who viewed your profile or showed interest.
  • Prepare for Due Diligence
    • Prepare for due diligence questions by interested investors and use your Business Plan and investment documents to satisfy such requests.
  • Keep Your Funding Profile Updated
    • Keep your funding profile updated with new funding raised/committed and message interested investors with any new milestones achieved.
  • Do Not Respond to Unknown Investors
    • Do not respond to or engage any parties outside of EquityNet that are not listed as approved investors (this may happen due to your public profile and LinkedIn connections).